Twist Bioscience (TWST) Cash & Current Investments (2018 - 2026)

Twist Bioscience (TWST) has reported Cash & Current Investments for 9 consecutive years, with $166.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Current Investments fell 33.48% year-over-year to $166.8 million in Q2 2026; TTM through Jun 2026 was $166.8 million, a 33.48% decrease from a year earlier, with the FY2025 full-year figure at $232.4 million, down 15.91% from the prior year.
• Cash & Current Investments was $166.8 million for Q2 2026 at Twist Bioscience, down from $171.7 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $573.9 million in Q1 2022 and troughed at $166.8 million in Q2 2026.
• A 5-year average of $324.7 million and a median of $291.4 million in 2024 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments surged 45.34% in 2022 and slumped 33.48% in 2026, its largest moves.
• Over 5 years, Cash & Current Investments stood at $438.7 million in 2022, then fell by 29.08% to $311.1 million in 2023, then dropped by 12.96% to $270.8 million in 2024, then dropped by 26.89% to $198.0 million in 2025, then fell by 15.74% to $166.8 million in 2026.
• The last three Cash & Current Investments figures came in at $166.8 million (Q2 2026), $171.7 million (Q1 2026), and $198.0 million (Q4 2025), per Business Quant data.